Form D · Biotechnology

OTHERA PHARMACEUTICALS, INC

Exton, PA · CIK 0001203928

Offering snapshot reported Aug 4, 2009 · SEC filing

Reported sold
$10.6M
Offering amount: $10.8M
Investors reported
26
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Oct 10, 2008
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$5.31M$10.6MOct 23, 2008Jun 23, 2009: $7,369,903.00Aug 4, 2009: $10,619,994.00Aug 4, 2009

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$7,369,903 → $10,619,994
  • Reported investors22 → 26

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 4, 2009Amendment$10,619,994$3,250,091vs Jun 23, 200926SEC filing
Jun 23, 2009Amendment$7,369,903No comparison22SEC filing
Oct 23, 2008PaperNot reportedNo comparisonNot reportedSEC filing
May 23, 2006PaperNot reportedNo comparisonNot reported
Apr 27, 2006PaperNot reportedNo comparisonNot reported

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-49840
Further proceeds include exercise price of Warrants to be issued at a later date, which exercise price is not yet determinable, and Warrants to purchase shares of Series C Convertible Preferred Stock at an aggregate exercise price of $1,769,994.

Source: Form D, filed Aug 4, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Katherine Crothall Director
Rami Elghandour Director
David S. Joseph Director, Executive
Thomas R. Morse Director
Hans Mueller Director
Brian G. Murphy Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
730 Springdale Drive
Exton, PA, 19341